We are live on ! Find out more
FCSC

Fibrocell Science Inc.
FCSC

Delisted

FCSC was delisted on the 12th of December, 2019.

Back to rankings

32 hedge funds and large institutions have $24.2M invested in Fibrocell Science Inc. in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

125% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 4

76% more call options, than puts

Call options by funds: $90K | Put options by funds: $51K

10% more funds holding

Funds holding: 29 → 32 (+3)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

25% less capital invested

Capital invested by funds: $32.3M → $24.2M (-$8.1M)

Holders
32
Holders Change
+3
Holders Change %
+10.34%
% of All Funds
0.8%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
9
Reduced
4
Closed
1
Calls
$90K
Puts
$51K
Net Calls
+$39K
Net Calls Change
-$1K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$154K
2
FO
FT Options
Illinois
+$123K
3
VF
Virtu Financial
New York
+$117K
4
ARTA
A.R.T. Advisors
New York
+$55.2K
5
Renaissance Technologies
Renaissance Technologies
New York
+$34K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$850K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$58.2K
3
SCA
STALEY CAPITAL ADVISERS
Pennsylvania
-$9.17K
4
UBS Group
UBS Group
Switzerland
-$7.02K
5
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
TS
1
Third Security
Virginia
$17M – – –
MP
2
MSD Partners
New York
$2.12M – – –
Fidelity Investments
3
Fidelity Investments
Massachusetts
$1.8M -$850K -52,560 -31%
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.01M -$58.2K -3,600 -5%
Renaissance Technologies
5
Renaissance Technologies
New York
$363K +$34K +2,100 +10%
Morgan Stanley
6
Morgan Stanley
New York
$259K +$154K +9,534 +130%
Cambridge Investment Research Advisors
7
Cambridge Investment Research Advisors
Iowa
$207K – – –
Creative Planning
8
Creative Planning
Kansas
$187K – – –
Geode Capital Management
9
Geode Capital Management
Massachusetts
$179K – – –
PPA
10
Parametric Portfolio Associates
Washington
$148K – – –
BlackRock
11
BlackRock
New York
$130K – – –
FO
12
FT Options
Illinois
$116K +$123K +7,600 New
California Public Employees Retirement System
13
California Public Employees Retirement System
California
$111K – – –
Bank of New York Mellon
14
Bank of New York Mellon
New York
$111K +$14.6K +900 +14%
VF
15
Virtu Financial
New York
$111K +$117K +7,240 New
SCA
16
STALEY CAPITAL ADVISERS
Pennsylvania
$92K -$9.17K -567 -9%
ARTA
17
A.R.T. Advisors
New York
$52K +$55.2K +3,415 New
CCA
18
Conservest Capital Advisors
Pennsylvania
$51K – – –
FSA
19
Franklin Street Advisors
North Carolina
$51K – – –
Susquehanna International Group
20
Susquehanna International Group
Pennsylvania
$51K +$10.8K +670 +25%
Northern Trust
21
Northern Trust
Illinois
$49K – – –
TRCT
22
Tower Research Capital (TRC)
New York
$8K +$6.19K +383 +302%
Wells Fargo
23
Wells Fargo
California
$6K +$113 +7 +2%
Simplex Trading
24
Simplex Trading
Illinois
$6K +$1.39K +86 +28%
JP Morgan Chase
25
JP Morgan Chase
New York
$3K +$1.94K +120 +300%
1
2

FCSC Hedge Fund Activity: Q3 2017 in Review

32 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q3 2017, worth a combined $24.2M — down 25% from $32.3M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new FCSC positions and 1 closed out — a net gain of 4 holders — while 9 added to existing stakes and 4 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $154K. The largest seller was Fidelity Investments, cutting an estimated $850K.

  • 32 institutional investors held Fibrocell Science Inc. (FCSC) as of Q3 2017, up from 29 in Q2 2017.
  • Funds reported $24.2M of Fibrocell Science Inc. stock for Q3 2017, down 25% quarter-over-quarter.
  • 5 funds opened new Fibrocell Science Inc. positions in Q3 2017 and 1 closed out, a net change of +4 holders.
  • The largest Fibrocell Science Inc. buyer in Q3 2017 was Morgan Stanley, an estimated $154K added.
  • The largest Fibrocell Science Inc. seller in Q3 2017 was Fidelity Investments, an estimated $850K sold.

Based on aggregated 13F filings for Q3 2017.